JP2008526750A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526750A5 JP2008526750A5 JP2007549533A JP2007549533A JP2008526750A5 JP 2008526750 A5 JP2008526750 A5 JP 2008526750A5 JP 2007549533 A JP2007549533 A JP 2007549533A JP 2007549533 A JP2007549533 A JP 2007549533A JP 2008526750 A5 JP2008526750 A5 JP 2008526750A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- peptide
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64141305P | 2005-01-04 | 2005-01-04 | |
| PCT/US2005/046951 WO2006078421A2 (en) | 2005-01-04 | 2005-12-23 | Methods of increasing cerebral blood flow |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526750A JP2008526750A (ja) | 2008-07-24 |
| JP2008526750A5 true JP2008526750A5 (https=) | 2009-10-08 |
Family
ID=36692699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549533A Pending JP2008526750A (ja) | 2005-01-04 | 2005-12-23 | 脳血流を増加させる方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7563772B2 (https=) |
| EP (1) | EP1846016A2 (https=) |
| JP (1) | JP2008526750A (https=) |
| KR (1) | KR20070103009A (https=) |
| CN (1) | CN101111257A (https=) |
| AU (1) | AU2005325128A1 (https=) |
| CA (1) | CA2592500A1 (https=) |
| WO (1) | WO2006078421A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002057413A2 (en) * | 2001-01-18 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for activation and inhibition of delta pkc |
| US7563772B2 (en) * | 2005-01-04 | 2009-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of increasing cerebral blood flow |
| US20090186814A1 (en) * | 2005-01-26 | 2009-07-23 | Fumiaki Ikeno | Methods and Compositions for Reducing Ischemia-Derived Microvascular Damage |
| US20070066526A1 (en) * | 2005-09-02 | 2007-03-22 | Daria Mochly-Rosen | Method for reducing risk of and extent of injury due to stroke in hypertensive subjects |
| US7741290B2 (en) * | 2006-06-01 | 2010-06-22 | The Board of Trustee of The Leland Stanford Juinior University | Method of preventing progression of hypertension-induced heart failure with PKC peptides |
| AU2007305268A1 (en) * | 2006-10-02 | 2008-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides derived from the C2 domain of epsilon PKC, and use thereof |
| WO2008097563A1 (en) * | 2007-02-06 | 2008-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for maintaining blood-brain barrier integrity in hypertensive subjects using a delta-pkc inhibitor |
| CA2698013A1 (en) * | 2007-08-27 | 2009-03-05 | Kai Pharmaceuticals, Inc. | Protein kinase c-d inhibitors that protect against cellular injury and inflammation and promote astrocyte proliferation |
| US20130274651A1 (en) | 2012-04-16 | 2013-10-17 | Denise Barbut | System and method for improving outcome of cerebral ischemia |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708871A (en) * | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| CZ280738B6 (cs) * | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi |
| US5380746A (en) * | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| US5804604A (en) * | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
| WO1993007294A1 (en) * | 1991-10-01 | 1993-04-15 | The United States Of America, Represented By The Secretary, Department Of Health And Human Service | A method of identifying ligands and antagonists of ligands |
| US5776716A (en) * | 1994-02-01 | 1998-07-07 | Terrapin Technologies, Inc. | Methods for identifying agents which block the interaction of fyn with PKC-theta, and uses thereof |
| US5935803A (en) | 1994-02-01 | 1999-08-10 | Terrapin Technologies, Inc. | Methods to identify immunomodulators using cognate interaction of PKC-theta |
| US5783405A (en) * | 1994-02-01 | 1998-07-21 | Terrapin Technologies, Inc. | Rapid screening method for effectors of signal transduction |
| US5559228A (en) * | 1995-03-30 | 1996-09-24 | Eli Lilly And Company | Synthesis of bisindolylmaleimides |
| US6255057B1 (en) * | 1996-07-26 | 2001-07-03 | Ernest Gallo Clinic And Research Center | Detection of cellular exposure to ethanol |
| WO1998017299A1 (en) * | 1996-10-18 | 1998-04-30 | The Board Of Trustees Of The Leland Stanford Junior University | Isozyme-specific activators of protein kinase c, methods and compositions |
| WO2001028550A1 (en) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
| WO2001028543A1 (en) | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-δ ACTIVITY |
| WO2001044497A2 (en) * | 1999-12-02 | 2001-06-21 | University Of Dundee | Protein kinase regulation |
| US20020048582A1 (en) * | 2000-07-18 | 2002-04-25 | King George L. | Methods of modulating angiogenesis |
| WO2002057413A2 (en) * | 2001-01-18 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for activation and inhibition of delta pkc |
| US20030134774A1 (en) * | 2001-06-15 | 2003-07-17 | Steinberg Susan F. | Methods for inhibiting cardiac disorders |
| US6933275B2 (en) * | 2002-05-01 | 2005-08-23 | The Board Of Trustees Of The Leland Stanford Junior University | Protein kinase C peptides for use in withdrawal |
| US20040259816A1 (en) * | 2002-10-01 | 2004-12-23 | Pandol Stephen J. | Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
| JP4567296B2 (ja) * | 2003-03-11 | 2010-10-20 | 株式会社リコー | 電子写真の画像位置検出方法およびこれを用いた記録装置 |
| US20050164324A1 (en) * | 2003-06-04 | 2005-07-28 | Gygi Steven P. | Systems, methods and kits for characterizing phosphoproteomes |
| WO2005107789A1 (en) * | 2004-04-30 | 2005-11-17 | The Board Of Trustees Of The Leland Stanford Junior University | Use of delta pkc peptides for modulation of reactive oxigen species |
| US7563772B2 (en) * | 2005-01-04 | 2009-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of increasing cerebral blood flow |
-
2005
- 2005-12-23 US US11/317,806 patent/US7563772B2/en not_active Expired - Fee Related
- 2005-12-23 WO PCT/US2005/046951 patent/WO2006078421A2/en not_active Ceased
- 2005-12-23 CA CA002592500A patent/CA2592500A1/en not_active Abandoned
- 2005-12-23 CN CNA2005800459632A patent/CN101111257A/zh active Pending
- 2005-12-23 KR KR1020077017309A patent/KR20070103009A/ko not_active Withdrawn
- 2005-12-23 EP EP05857205A patent/EP1846016A2/en not_active Withdrawn
- 2005-12-23 JP JP2007549533A patent/JP2008526750A/ja active Pending
- 2005-12-23 AU AU2005325128A patent/AU2005325128A1/en not_active Abandoned
-
2009
- 2009-06-23 US US12/490,097 patent/US8492348B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ishrat et al. | Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats | |
| ES2517340T3 (es) | Tratamiento de la hipertensión portal usando L-ornitina y fenilacetato | |
| ES2765281T3 (es) | Coadministración de un agente unido a un péptido de interiorización con un agente antiinflamatorio | |
| Sredni et al. | Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models | |
| CN102791279A (zh) | 用于进行冠状动脉旁路移植手术的方法 | |
| CN106170491B (zh) | 神经保护肽 | |
| Chugh et al. | Cerebral vasospasm and delayed cerebral ischemia: Review of literature and the management approach | |
| WO2000051623A2 (en) | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions | |
| RU2017121203A (ru) | НОВЫЕ ПОЛИМЕРНЫЕ hGH ПРОЛЕКАРСТВА | |
| RU2009128245A (ru) | Применение гена сывороточного амилоида а для диагностики и лечения глаукомы и идентификации антиглаукомных агентов | |
| JP2008526750A5 (https=) | ||
| HRP20120896T1 (hr) | Uporaba antagonista il-1 za lijeäśenje gihta i pseudogihta | |
| TWI351950B (en) | Use of (halobenzyloxy) benzylamino-propanamides fo | |
| US12252554B2 (en) | Analogs that target mitochondrial diseases | |
| US10772827B2 (en) | Composition for treating apoplexy through nasal administration | |
| JPWO2020148525A5 (https=) | ||
| ES2311973T3 (es) | Ctgf como objetivo para la terapia de microalbuminuria en pacientes con nefropatia diabetica. | |
| US11571455B2 (en) | Methods and compositions for treating alcoholic liver disease | |
| JPWO2020148529A5 (https=) | ||
| JP5053665B2 (ja) | 催眠用医薬組成物 | |
| Dugue et al. | Controlled cortical impact-induced neurodegeneration decreases after administration of the novel calpain-inhibitor Gabadur | |
| US20230255943A1 (en) | Mmp-9 and mmp-12 inhibition for treating spinal cord injury or related injury to neurological tissue | |
| ES2366570T3 (es) | Asociación de un inhibidor de la corriente if sinusal y de un inhibidor de la enzima de conversión de la angiotensina. | |
| WO2008004653A1 (en) | Prophylactic or therapeutic agent for viral disease | |
| CN106928322A (zh) | 一种具有抗脑缺血作用的融合多肽及其应用 |